TXN Texas Instruments Inc

Texas Instruments designs and manufactures analog and embedded processing semiconductors for industrial, automotive, personal electronics, and communications markets. Sector: Technology.

Texas Instruments Inc (TXN) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 20.16%, WACC is 9.29%, and the economic spread is 10.88%. On balance, the economic spread is positive and meaningful, suggesting the company are building rather than eroding intrinsic value. Supporting metrics show ROE at 30.21% and ROA at 12.66%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

From a market pricing perspective, trailing P/E of 35.79, forward P/E of 30.19, PEG of 1.99. A modest gap between trailing and forward multiples implies the market is pricing incremental earnings improvement rather than a step-change in profitability. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The company carries a current ratio of 4.35, pointing to strong short-term financial health. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin stack reads as follows: gross margin sits at 57.02%, operating margin at 34.69%, and free cash flow margin at 14.72%. The gross margin reading points to the company with solid but not outsized pricing power relative to direct costs. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Where growth and expectations intersect, the estimated 12-month price change of 14.73%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 10.38% suggesting the company is growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 18.5% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.